Disruption of the Novel Nested Gene Aff3ir Mediates Disturbed Flow-Induced Atherosclerosis in Mice

Shuo He; Lei Huang; Zhuozheng Chen; Ze Yuan; Yue Zhao; Lingfang Zeng; Yi Zhu; Jinlong He

doi:10.7554/eLife.103413.1

eLife Assessment

This important study describes a novel flow-responsive gene and its role in regulating the inflammation-associated transcription factor IRF5. While the in vivo experiments are solid, the in vitro data is inadequate since embryonic fibroblasts are used throughout despite the work aiming to investigate mechanisms of endothelial cell activation in atherosclerosis.

https://doi.org/10.7554/eLife.103413.1.sa3

Significance of findings

important: Findings that have theoretical or practical implications beyond a single subfield

landmark
fundamental
important
valuable
useful

Strength of evidence

solid: Methods, data and analyses broadly support the claims with only minor weaknesses

inadequate: Methods, data and analyses do not support the primary claims

exceptional
compelling
convincing
solid
incomplete
inadequate

During the peer-review process the editor and reviewers write an eLife assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) and the strength of the evidence (on a scale ranging from exceptional to inadequate). Learn more about eLife assessments

Abstract

Disturbed shear stress-induced endothelial atherogenic responses are pivotal in the initiation and progression of atherosclerosis, contributing to the uneven distribution of atherosclerotic lesions. This study investigates the role of Aff3ir-ORF2, a novel nested gene variant, in disturbed flow-induced endothelial cell activation and atherosclerosis. We demonstrate that disturbed shear stress significantly reduces Aff3ir-ORF2 expression in athero-prone regions. Using three distinct mouse models with manipulated AFF3ir-ORF2 expression, we demonstrate that AFF3ir-ORF2 exerts potent anti-inflammatory and anti-atherosclerotic effects in ApoE^-/- mice. RNA sequencing revealed that interferon regulatory factor 5 (IRF5), a key regulator of inflammatory processes, mediates inflammatory responses associated with AFF3ir-ORF2 deficiency. AFF3ir-ORF2 interacts with IRF5, promoting its retention in the cytoplasm, thereby inhibiting the IRF5-dependent inflammatory pathways. Notably, IRF5 knockdown in AFF3ir-ORF2 deficient mice almost completely rescues the aggravated atherosclerotic phenotype. Moreover, endothelial-specific AFF3ir-ORF2 supplementation using the CRISPR/Cas9 system significantly ameliorated endothelial activation and atherosclerosis. These findings elucidate a novel role for AFF3ir-ORF2 in mitigating endothelial inflammation and atherosclerosis by acting as an inhibitor of IRF5, highlighting its potential as a valuable therapeutic approach for treating atherosclerosis.

Introduction

Atherosclerosis, characterized by the formation of fibrofatty lesions in the arterial wall, is a leading cause of morbidity and mortality worldwide, contributing to most myocardial infarctions and many strokes (Herrington, Lacey, Sherliker, Armitage, & Lewington, 2016; Libby et al., 2019). The activation of vascular endothelial cells (ECs), induced by various chemical and mechanical stimuli, such as lipopolysaccharide and shear stress, is an initial step in the development of atherosclerosis (Davignon & Ganz, 2004). Consequently, atherosclerotic lesions preferentially develop at the branches and curvatures of the arterial tree, where blood flow is disturbed (Davis, Earley, Li, & Chien, 2023). For decades, researchers have been interested in exploring the mechanisms underlying mechanotransduction during endothelial activation caused by disturbed flow (Davis et al., 2023). Several mechanosensitive proteins, such as YAP/TAZ (B. Li et al., 2019), Annexin A2 (Zhang et al., 2020), BMP4 (Sorescu et al., 2004), and NAD(P)H oxidase (Hwang et al., 2003; Jo, Song, & Mowbray, 2006), have been identified as key regulators of disturbed shear stress in ECs and have been implicated in the progression of atherosclerosis. Emerging evidence has revealed that pharmacological or genetic inhibition of endothelial YAP activation ameliorates the progression of atherosclerotic plaques in mice (B. Li et al., 2019; Wang et al., 2016; Yang et al., 2021), indicating that targeting disturbed flow-induced endothelial activation could be a promising therapeutic strategy for atherosclerosis. However, the precise mechanisms by which the disturbed flow exerts detrimental effects remain unclear.

The interferon regulatory factor (IRF) family of transcription factors, comprising nine members (IRF1-IRF9) in mammals, is primarily characterized by its role in mediating antiviral responses and type I interferon production (Sato, Taniguchi, & Tanaka, 2001). Although these members share a conserved DNA-binding domain in their N-terminal region that recognizes similar DNA sequences, IRF5 plays a central role in inflammation (Almuttaqi & Udalova, 2019; Takaoka et al., 2005). IRF5 mediates the production of proinflammatory cytokines, including IL-12b and IL-23a, and promotes the expression of inflammatory genes (Cai, Yao, & Li, 2017; Saliba et al., 2014; Weiss, Blazek, Byrne, Perocheau, & Udalova, 2013). It promotes inflammatory responses in various immune cells, including macrophages (Seneviratne et al., 2017), neutrophils (Weiss et al., 2015), and B cells (Savitsky, Yanai, Tamura, Taniguchi, & Honda, 2010). Global or myeloid-specific knockouts of IRF5 have been shown to exert anti-atherosclerotic effects (Leipner et al., 2021; Seneviratne et al., 2017). Despite the established importance of IRF5 in immune cells, its restrictively regulatory mechanism and role in shear stress-induced endothelial activation remain unknown.

We recently reported that a novel protein-coding nested gene, Aff3ir, contributes to endothelial maintenance by promoting the differentiation of vascular stem/progenitor cells (SPCs) into ECs (Zhao Y et al., 2024). AFF3ir-ORF2, encoded by the Aff3ir transcript variant 2, is predominantly expressed in the EC layer of the mouse aorta (Zhao Y et al., 2024). Notably, our recent study indicated that the overexpression of AFF3ir-ORF2 could enhance laminar flow-induced mRNA levels of essential EC markers in SPCs (Zhao Y et al., 2024), suggesting that AFF3ir-ORF2 may be a novel mechanotransduction protein in ECs. However, the regulation of Aff3ir-ORF2 under disturbed flow and its role in atherosclerosis remain unclear.

In this study, we aimed to elucidate the mechanism by which disturbed blood flow induces endothelial activation and atherosclerosis. Our study showed that disrupted Aff3ir-ORF2 expression in athero-prone regions led to inflammatory responses and development of atherosclerosis. Aff3ir-ORF2, the expression of which is reduced by disturbed shear stress, exerts critical anti-inflammatory effects by binding to IRF5 and mitigating disturbed shear stress-induced IRF5 activation. Additionally, we demonstrated that endothelial-specific supplementation with Aff3ir-ORF2 significantly ameliorated disturbed flow-induced endothelial activation and the development of atherosclerotic plaques, highlighting its promising therapeutic potential for the treatment of atherosclerosis.

Results

Disturbed shear stress reduces the expression of AFF3ir-ORF2

Our recent study showed the active participation of Aff3ir in EC differentiation from vascular SPCs induced by laminar shear stress (Zhao Y et al., 2024), suggesting the potential involvement of this novel protein-encoding nested gene in mediating hemodynamic stimulation. To further elucidate the functional role of Aff3ir and its encoded proteins in disturbed shear stress-induced EC activation, we examined the expression of AFF3 and AFF3ir in segments of the mouse aorta. We found that the mRNA level of AFF3ir, but not that of its parent gene AFF3, was significantly lower in the aortic arch, an area exposed to disturbed shear stress, than in the thoracic aorta, which was exposed to steady unidirectional shear stress (B. Li et al., 2019) (Figure 1A). Aff3ir transcript variants can generate two proteins (Zhao Y et al., 2024), therefore, we measured the protein levels of AFF3ir-ORF1 and AFF3ir-ORF2. While AFF3ir-ORF1 and AFF3 showed comparable expression levels in the aortic arch and thoracic aorta of mice, the expression of AFF3ir-ORF2 showed an 87% reduction in the aortic arch compared to the thoracic aorta (Figure 1B, C), suggesting that AFF3ir-ORF2 may be a novel mechanosensitive protein that responds to disturbed shear stress. Enface immunofluorescence staining confirmed a marked reduction in AFF3ir-ORF2 expression in the aortic arch compared to that in the thoracic aorta (Figure 1D, E). Moreover, we observed the expression of AFF3ir-ORF2 in longitudinal sections of the mouse aorta (B. Li et al., 2019). We found that the expression of AFF3ir-ORF2, but not AFF3, was notably downregulated in athero-prone regions (the inner curvature of the aortic arch and bifurcation of the carotid artery) compared to that in the protective region in the outer curvature of the aortic arch (Figure 1F).

Next, we explored the impact of disturbed shear stress on AFF3ir-ORF2 expression in vitro. Mouse embryonic fibroblasts (MEFs) exhibit responses consistent with those of ECs (Chen et al., 2010; Wen et al., 2013), therefore, we investigated AFF3ir-ORF2 expression in MEFs from WT mice exposed to static or disturbed flow (0.5 ± 4 dyn/cm², 1 Hz). Consistent with our in vivo findings, while disturbed shear stress increased the expression of VCAM-1, a critical inflammatory marker of ECs (Nakashima, Raines, Plump, Breslow, & Ross, 1998), it significantly reduced both the protein and mRNA levels of AFF3ir-ORF2 (Figure 1G–I). The expression of AFF3 in response to the disturbed flow was minimally affected at both the mRNA and protein levels (Figure 1G–I). These results collectively demonstrate that disturbed shear stress induces a reduction in AFF3ir-ORF2 expression both in vivo and in vitro.

AFF3ir-ORF2 ameliorates disturbed shear stress-induced inflammation and atherosclerosis

Disturbed shear stress-induced atherogenic responses are initial events in atherosclerotic plaque formation (Davis et al., 2023). To elucidate the regulatory role of AFF3ir-ORF2 in disturbed shear stress-induced inflammation, we overexpressed AFF3ir-ORF2 in MEFs. AFF3ir-ORF2 overexpression attenuated ICAM-1 expression induced by disturbed shear stress at both the protein and mRNA levels (Figure 2A–C). Additionally, AFF3ir-ORF2 overexpression blunted the disturbed shear stress-induced expression of several other inflammatory genes, including VCAM-1, IL-6, and IL-1β (Figure 2C).

AFF3ir-ORF2 overexpression alleviates disturbed flow-induced inflammation and atherosclerosis.
**A–C,** Mouse embryonic fibroblasts (MEFs) isolated from C57BL/6 mice were infected with indicated adenoviruses (Ad-Scramble or Ad-Aff3ir-ORF2) for 48 h and then exposed to static (ST) or oscillatory shear stress (OSS, 0.5 ± 4 dyn/cm², 1 Hz) for another 6 h. A, B, Western blot analysis of the indicated proteins in MEFs and quantification of their relative expression of proteins are shown. The protein levels were normalized to GAPDH and the relative expression of the values is relative to MEFs infected with Ad-Scramble and treated with ST. Data are presented as mean ± SEM (n = 6 independent experiments). *P< 0.05, two-way ANOVA with Tukey post-test. C, RT-PCR analysis of mRNA levels of *AFF3, AFF3ir, VCAM-1, ICAM-1,* interleukin-6 (*IL-6*), and interleukin-1 beta (*IL-1β*). The relative expression of the values is relative to MEFs infected with Ad-Scramble and treated with ST. Data are presented as mean ± SEM (n = 6 independent experiments). *P< 0.05, two-way ANOVA with Tukey post-test. **D–H,** Eight-week-old male ApoE^−/− mice were subjected to partial ligation of the carotid artery along with 10 μL of adenovirus suspension at 1 × 10⁸ transducing units (TU)/mL was instilled into the left carotid artery (LCA). The mice were then fed high-fat diet for 4 weeks. D, Arterial tissues were isolated to examine the atherosclerotic lesions. Scale bar, 2 mm. **E, F,** LCAs were sectioned for hematoxylin and eosin staining and quantification of the lesion area. Scale bar, 25 μm. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test. G, H, Immunofluorescence staining for vWF, VCAM-1, and DAPI in the LCA, and quantification of the relative fluorescent intensity of VCAM-1. The immunofluorescence intensity of VCAM-1 was normalized to DAPI, and the relative expression of the values were relative to that of the Ad-Scramble group. Scale bar, 50 μm. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test.

Given the anti-inflammatory effects of AFF3ir-ORF2, we speculated that it may ameliorate disturbed shear stress-induced inflammation and atherosclerosis in vivo. ApoE knockout (ApoE^-/-) mice were subjected to partial ligation surgery to induce disturbed flow in the left carotid arteries (LCAs). The endothelium of the LCAs was intravascularly infected with adenovirus (Ad-Scramble or Ad-AFF3ir-ORF2) prior to surgery (Nam et al., 2009; Zhang et al., 2020). Enface immunofluorescence staining confirmed the successful AFF3ir-ORF2 overexpression in the left carotid artery (Figure S1A). Mice infected with Ad-AFF3ir-ORF2 exhibited a significant decrease in lesion area in the LCAs compared to those infected with Ad-Scramble (23±17% vs 63±14%) (Figure 2D–F). Overexpression of AFF3ir-ORF2 also attenuated disturbed flow-induced inflammatory responses, as evidenced by decreased VCAM-1 expression in the endothelium of LCAs (Figure 2G, H). These findings suggested that AFF3ir-ORF2 ameliorates shear stress-induced inflammation and atherosclerosis.

AFF3ir-ORF2 deficiency aggravates inflammation and atherosclerotic lesions in ApoE^-/- mice

To explore the effects of AFF3ir-ORF2 on inflammation and atherosclerosis, we generated AFF3ir-ORF2 global knockout (AFF3ir-ORF2^-/-) mice. No obvious phenotypic abnormalities were observed in AFF3ir-ORF2^-/- mice up to 20 weeks of age and monitoring was discontinued thereafter. Additionally, AFF3ir-ORF2 deficiency did not alter systolic blood pressure, diastolic blood pressure, or mean arterial pressure (Figure S2A), suggesting that AFF3ir-ORF2 is dispensable for physiological blood pressure maintenance. We then isolated MEFs from WT and AFF3ir-ORF2^-/- mice. RT-PCR analysis confirmed the deficiency of AFF3ir-ORF2 in AFF3ir-ORF2^-/- MEFs (Figure S2B). Under disturbed flow stimulation, AFF3ir-ORF2 deficient MEFs displayed higher expression of inflammatory genes, including ICAM-1, VCAM-1, and IL-1b, compared to those in WT MEFs (Figure S2C).

Next, we crossed AFF3ir-ORF2^-/- mice with ApoE^-/- mice to generate double-knockout (ApoE^-/-AFF3ir-ORF2^-/-) mice. Eight-week-old ApoE^-/- and ApoE^-/-AFF3ir-ORF2^-/- mice were fed a high-fat diet for 12 weeks to induce atherosclerosis (Figure 3A). En face Oil-Red O staining indicated that AFF3ir-ORF2 deficiency accelerated the development of atherosclerosis in the entire aorta (Figure 3B, C). Furthermore, AFF3ir-ORF2 deletion increased the lesion area and lipid deposition in the aortic roots of ApoE^-/- mice without altering the collagen fiber content (Figure 3D, E). Similar results were observed in distributing arteries (LCAs) (Figure 3F, G). Given that the expression of adhesion proteins, such as VCAM-1 in ECs is crucial for monocyte infiltration into plaques (Kobiyama & Ley, 2018), we assessed VCAM-1 expression in the aortic roots of these mice. We found that AFF3ir-ORF2 deletion increased VCAM-1 expression in the aortic roots of ApoE^-/- mice (Figure 3H, I), indicating that the atherogenic effects of AFF3ir-ORF2 deletion may result from endothelial inflammation. Additionally, there were no significant differences between the two groups in body weight or triglyceride, total cholesterol, LDL cholesterol, and HDL cholesterol levels (Figure S3A, B), indicating that the atherogenic effect of AFF3ir-ORF2 silencing is unlikely to be related to lipid metabolism. Taken together, these results indicate that AFF3ir-ORF2 deficiency aggravates inflammation and atherosclerotic lesions in mice.

AFF3ir-ORF2 deletion aggravates inflammation and atherosclerotic lesions in ApoE^-/- mice.
Eight-week-old male ApoE^-/- and ApoE^-/-AFF3ir-ORF2^-/- mice were fed a high-fat diet for 12 weeks. Arterial tissues and aortic roots were isolated to examine atherosclerotic lesions. A, Schematic of experimental strategy. B, Representative images of en face Oil-Red O staining of the aortas. Scale bar, 4 mm. C, Quantification of the plaque area in the aortas. Data are presented as mean ± SEM (n=12 mice per group). *P< 0.05, unpaired two-tailed t-test. D, Oil-Red O, hematoxylin and eosin (HE), and Masson staining of the aortic roots. Scale bars, 500 μm. E, Quantification of plaque size, Oil-Red O-positive area, and collagen fiber content in aortic root sections. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test. F, LCAs were sectioned and stained with Oil-Red O, HE, and Masson’s trichrome. Scale bars, 500 μm. G, Quantification of plaque size, Oil-Red O-positive area, and collagen fiber content in the LCA sections. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test. H: Representative immunofluorescence images of vWF, VCAM-1, and DAPI in the aortic roots. Scale bar, 500 μm. I, Quantification of the relative fluorescence intensity of VCAM-1. The immunofluorescence intensity of VCAM-1 was normalized to that of DAPI, and the relative expression of the values were relative to that of the ApoE^-/- group. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test.

AFF3ir-ORF2 mitigates disturbed shear stress-induced inflammation by interacting with IRF5 and retaining it within the cytosol

To explore the mechanism by which AFF3ir-ORF2 mitigates atherogenesis, we performed RNA sequencing (RNA-seq) on MEFs from WT and AFF3ir-ORF2^-/- mice. We identified 1,167 upregulated and 310 downregulated genes in the AFF3ir-ORF2^-/- group, with a criterion of 1.5-fold change and P<0.05 (Figure 4A, B). Differentially expressed genes were subjected to bioinformatics enrichment analysis using Gene Ontology (GO) databases. GO analysis showed that these genes were mainly enriched in processes, including leukocyte cell-cell adhesion, regulation of cell−cell adhesion, and leukocyte activation involved in immune response (Figure 4C), which is highly consistent with the phenotypes observed in AFF3ir- ORF2^-/- mice. To further identify the upstream transcriptional regulators of these genes, we predicted upstream transcription factors using the ChEA3 database (Keenan et al., 2019). The top 20 transcription factors obtained from the ChEA3 database were mapped to the atherosclerotic disease-related gene list in the Disgenet database (Pinero et al., 2017). Interferon regulatory factor 5 (IRF5) and IRF8 were identified as key upstream regulators (Figure 4D).

IRF5 and IRF8, which are members of the same family of transcription factors originally implicated in interferon production, have been identified as critical regulators of the inflammatory response and contribute to the pathogenesis of various inflammatory diseases (Almuttaqi & Udalova, 2019; Salem, Salem, & Gros, 2020). However, their potential roles in disturbed shear stress-induced inflammation remain unclear. We speculated that AFF3ir-ORF2 interacts with IRF5 and/or IRF8. Coimmunoprecipitation assays indicated that endogenous AFF3ir-ORF2 could bind to both IRF5 and IRF8 (Figure 4E). To determine which transcription factor that mediates the inflammatory effects of AFF3ir-ORF2 deficiency, we silenced IRF5 and IRF8 in WT and AFF3ir-ORF2^-/- MEFs exposed to disturbed flow. Notably, silencing IRF5, but not IRF8, blunted the upregulation of inflammatory genes, including ICAM-1, VCAM-1, IL-6, and IL-1β (Figure 4F), suggesting that IRF5 was the predominant factor mediating the anti-inflammatory effects of AFF3ir-ORF2 in the context of disturbed shear stress. In addition, neither IRF5 nor IRF8 expression was regulated by AFF3ir-ORF2 (Figure 4F). Consistently, we found that IRF5 silencing significantly inhibited the upregulation of ICAM-1 protein levels induced by AFF3ir-ORF2 deficiency under disturbed shear stress (Figure 4G, H). Given that the transcriptional activity of IRF5 depends on its nuclear translocation (Lv et al., 2024), we next explored whether AFF3ir-ORF2 affects the subcellular localization of IRF5. Subcellular fractionation assays indicated that IRF5 was predominantly localized in the cytoplasm under static conditions, but exhibited obvious nuclear localization when exposed to disturbed shear stress (Figure 4I, J). While the total expression of IRF5 was barely affected by AFF3ir-ORF2 deficiency or overexpression, nuclear localization of IRF5 increased with AFF3ir-ORF2 deficiency (Figure 4I, J). To further ascertain the role of AFF3ir-ORF2 in regulating the transcriptional activity of IRF5, we performed a luciferase reporter assay (Qiao, Lv, Qiao, Wang, & Miao, 2022). AFF3ir-ORF2 overexpression significantly decreased the transcriptional activity of IRF5 (Figure 4K). In summary, these results suggested that AFF3ir-ORF2 acts as an endogenous inhibitor of IRF5 and exerts anti-inflammatory effects by retaining IRF5 in the cytosol.

IRF5 knockdown prevents the aggravation of atherosclerosis induced by ORF2 deficiency

Next, we investigated the role of IRF5 in disturbed flow-induced atherosclerosis in vivo and whether it mediates the atherogenic phenotype associated with AFF3ir-ORF2 deficiency. ApoE^-/- and ApoE^-/-AFF3ir-ORF2^-/- mice were subjected to partial ligation surgery in the LCAs and intravascularly infected with lentiviruses expressing either IRF5-specific shRNA (lenti-shIRF5) or Scramble shRNA (lenti-shScramble). En-face immunofluorescence staining confirmed successful IRF5 deletion in the left carotid artery (Figure S4A). After a 4-week high-fat diet challenge, IRF5 deletion resulted in an approximately 60% reduction in plaque area in the LCAs of ApoE^-/- mice (Figure 5A, B). In addition, IRF5 deletion attenuated endothelial activation, as evidenced by reduced VCAM-1 expression in the endothelium of LCAs (Figure 5C, D). Notably, although ApoE^-/-AFF3ir-ORF2^-/- mice exhibited an increased plaque area in the LCAs compared to ApoE^-/- mice, IRF5 deletion almost completely abolished these differences, reducing both the plaque area and VCAM-1 expression in the endothelium of the LCAs (Figure 5A–D). These findings provide in vivo evidence that AFF3ir-ORF2 deficiency-induced atherosclerosis is mediated by endothelial IRF5.

IRF5 knockdown prevents the aggravation of atherosclerosis in AFF3ir-ORF2 deficienct mice.
Eight-week-old male ApoE^-/- mice were subjected to partial ligation of the left carotid artery (LCA) along with 10 μL of lentivirus suspension at 1 × 10⁸ transducing units (TU)/mL was instilled into the LCA. The mice were then fed a high-fat diet for 4 weeks. A, Arterial tissues were isolated to examine the atherosclerotic lesions. Scale bar, 2 mm. B, LCAs were sectioned for hematoxylin and eosin staining and quantification of the lesion area. Scale bar, 25 μm. Data are mean ± SEM (n=6 mice per group). *P< 0.05, two-way ANOVA with Tukey post-test. **C, D,** Immunofluorescence staining for vWF, VCAM-1, and DAPI in the LCAs and quantification of the relative fluorescent intensity of VCAM-1. Scale bar, 50 μm. The immunofluorescence intensity of VCAM-1 was normalized to DAPI, and the relative expression of the values were relative to that of the group of ApoE^-/- mice infected with Ad-scramble. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, two-way ANOVA with Tukey post-test.

Endothelial-specific AFF3ir-ORF2 supplementation ameliorates EC activation and atherosclerosis in mice

Given the significant anti-inflammatory effects of AFF3ir-ORF2 on endothelial activation and atherosclerosis, we explored the potential use of gene therapy targeting AFF3ir-ORF2 to treat atherosclerosis. Endothelial-specific AFF3ir-ORF2 overexpression was achieved using an EC- enhanced AAV-mediated CRISPR/Cas9 genome-editing system controlled by an EC-specific ICAM2 promoter as we previously reported (Z. Li et al., 2024; Swiech et al., 2015). ApoE^-/- mice infected with AAV-ICAM2-Control or AAV-ICAM2- AFF3ir-ORF2 were fed a high-fat diet for 12 weeks (Figure 6A). En-face immunofluorescence staining confirmed successful AFF3ir-ORF2 overexpression in ECs (Figure S5A, B). Endothelial-specific AFF3ir-ORF2 overexpression had a minimal effect on triglycerides, total cholesterol, LDL cholesterol, and HDL cholesterol levels in the plasma of mice (Figure S5C). However, compared to the negative control, endothelial-specific AFF3ir-ORF2 overexpression significantly reduced the Oil-red O-positive lesion area in the whole aortas of ApoE^-/- mice (19±5% vs 54±8%) (Figure 6B, C). Moreover, endothelial-specific AFF3ir-ORF2 overexpression reduced the lesion area and lipid deposition in the aortic roots of ApoE^-/- mice without altering the collagen fiber content (Figure 6D, E). In addition, AFF3ir-ORF2 overexpression effectively suppressed VCAM-1 expression in the endothelium of the aortic roots of ApoE^-/- mice (Figure 6F, G). Collectively, these results suggest that supplementation with AFF3ir-ORF2 was effective in preventing atherosclerosis development.

Endothelial-specific AFF3ir-ORF2 supplementation alleviates EC activation and atherosclerosis in ApoE^-/- mice.
Eight-week old ApoE^-/- male mice were infused with the indicated adeno-associated virus (AAV) and then fed a high-fat diet for 12 weeks. A, Schematic of the experimental strategy. B, Representative images of enface Oil-Red O staining of the aortas. Scale bar, 4 mm. C, Quantification of the plaque area in the entire aortas. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test. D, Hematoxylin and eosin (HE), Oil-Red O, and Masson staining of the aortic roots. Scale bars, 500 μm. E, Quantification of plaque size, Oil-Red O-positive area, and collagen fiber content in aortic root sections. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test. F, Representative immunofluorescence image of vWF, VCAM-1, and DAPI in the aortic roots. Scale bar, 500 μm. G, Quantification of the relative fluorescent intensity of VCAM-1. The immunofluorescence intensity of VCAM-1 was normalized to that of DAPI, and the relative expression of the values were relative to that of the AAV-Scramble group. Data are presented as mean ± SEM (n=6 mice per group). *P< 0.05, unpaired two-tailed t-test.

Discussion

Endothelial activation is a critical initial event in the development of atherosclerosis, and emerging evidence suggests that targeting disturbed shear stress-induced endothelial activation is a promising therapeutic strategy. In the present study, we elucidated the role of the novel nested gene-encoded protein, AFF3ir-ORF2, in sensing disturbed shear stress. Moreover, we demonstrated that AFF3ir-ORF2 acts as an endogenous inhibitor of IRF5, a key regulator of the inflammatory response, thereby exerting potent anti-inflammatory and anti- atherogenic effects (Figure 7).

Schematic illustration of the AFF3ir-ORF2/IRF5 cascade in disturbed flow-induced endothelial activation and atherosclerosis.
Disturbed flow induced a down-regulation of AFF3ir-ORF2, which could interact with IRF5 and promote the latter’s retention in the cytoplasm, thereby boosting IRF5-dependent inflammatory pathways in endothelial cells and leading to atherogenesis.

Using three mouse models (global AFF3ir-ORF2 knockout, locally AFF3ir-ORF2 endothelial expression, and endothelial-specific AFF3ir-ORF2 overexpression), we demonstrated that AFF3ir-ORF2 exerted potent anti-inflammatory and anti-atherosclerosis effects in ApoE^-/- mice. Notably, while AFF3ir-ORF2 knockout increased VCAM-1 expression in the endothelium and enlarged the plaque area in the aortic roots, it had a minimal effect on collagen deposition within the plaques. This discrepancy may be attributed to the differential expression patterns of IRF5 across various cell types (Roberts, Collado, & Barnes, 2024). Phenotypically modulated vascular smooth muscle cells (VSMCs) within the fibrous cap produce extracellular matrix molecules critical for plaque composition and stabilization (Bennett, Sinha, & Owens, 2016). A previous study has shown minimal colocalization between IRF5 and the VSMC marker, α-smooth muscle actin, in aortic root lesions of ApoE^-/- mice (Seneviratne et al., 2017), indicating a relatively low IRF5 expression level in VSMCs. Consequently, AFF3ir-ORF2 likely exerts its anti-inflammatory effects primarily through endothelial IRF5. Consistently, endothelial-specific AFF3ir-ORF2 overexpression reduced the aortic plaque area, but had minimal effects on collagen deposition. Our findings establish the potent anti-atherosclerotic role of AFF3ir-ORF2 in early and advanced atherosclerosis mouse models. However, given the multiple critical roles of ECs throughout the initiation and progression of atherosclerosis, further investigations are needed to explore the potential role of AFF3ir-ORF2 in other atherosclerotic processes, including endothelial-to-mesenchymal transition, plaque rupture, and atherothrombotic occlusion. Additionally, we found that disturbed shear stress transcriptional downregulated the expression of AFF3ir. However, the protein levels of AFF3ir-ORF2, but not those of AFF3ir-ORF1, were reduced by disturbed shear stress. Since both AFF3ir-ORF1 and AFF3ir-ORF2 are derived from AFF3ir, different translation mechanisms may be involved in the production of AFF3ir-ORF1/2.

In addition to ECs, various other cell types, particularly immune cells, play crucial roles in the progression of atherosclerotic plaques (Wolf & Ley, 2019). Macrophage polarization and inflammatory responses accelerate plaque development, leading to an increase in necrotic core and vulnerable plaques (Krausgruber et al., 2011). Elevated IRF5 expression and nuclear localization have been observed in macrophages within plaques of ApoE^-/- mice (Seneviratne et al., 2017). IRF5 has been demonstrated to drive macrophages towards a pro-inflammatory state, thereby affecting plaque stability (Seneviratne et al., 2017). Global or myeloid cell- specific deletion of IRF5 stabilizes atherosclerotic plaques by suppressing the inflammatory phenotypes of macrophages (Leipner et al., 2021; Seneviratne et al., 2017). Despite these findings, the role of IRF5 in shear stress-induced endothelial activation remains largely unknown. Our study provides evidence that disturbed shear stress is sufficient to induce IRF5 nuclear translocation and activation in ECs. Furthermore, IRF5 knockdown in ECs significantly reduced disturbed flow-induced plaque formation in LCAs. These findings suggest that targeting endothelial IRF5 may be an effective strategy for combating the early stages of atherosclerosis.

Given the key role of IRF5 in mediating inflammatory responses, it has been considered as an attractive therapeutic target, and various strategies have been developed to study and modulate its function (Almuttaqi & Udalova, 2019). For example, nanoparticle-delivered siRNA targeting IRF5 in macrophages promotes inflammation resolution, improves infarct healing, and attenuates post-myocardial infarction remodeling (Courties et al., 2014). Additionally, manipulating IRF5 protein levels through the E3 ubiquitin ligase, TRIM21, has been explored as a strategy for modulating its activity (Lazzari et al., 2014). Given the crucial physiological role of IRF5, strategies aimed at suppressing its pathophysiological activation without altering basal levels may offer additional benefits. Our study introduces a novel approach to inhibit IRF5 activation. We found that the novel nested gene-encoded protein, AFF3ir-ORF2, interacts with IRF5, leading to cytoplasmic retention and inactivation under disturbed shear stress conditions. Importantly, endothelium-specific supplementation with AFF3ir-ORF2 effectively attenuated endothelial activation and reduced the atherosclerotic plaque area in ApoE^-/- mice, suggesting that targeting endothelial IRF5 activation with AFF3ir-ORF2 holds promise for the treatment of atherosclerosis. Furthermore, as emerging studies have highlighted the substantial contributions of IRF5 to autoimmune diseases (Graham et al., 2006), neuropathic pain (Masuda et al., 2014), obesity (Dalmas et al., 2015), and hepatic fibrosis (Alzaid et al., 2016), future research should investigate whether AFF3ir- ORF2 has beneficial effects in these contexts.

Conclusion

In conclusion, this study provides novel evidence that the disruption of AFF3ir-ORF2 expression under disturbed flow promotes endothelial inflammatory responses and atherosclerosis. AFF3ir-ORF2 serves as an endogenous inhibitor of IRF5 by binding to IRF5 and preventing its nuclear translocation. Supplementation with endothelial AFF3ir-ORF2 may be a promising therapeutic strategy for treating atherosclerosis.

Materials and methods

Animals

C57BL/6 and Apolipoprotein E-null (ApoE^-/-) mice were purchased from the Experimental Animal Centre of Military Medical Science Academy (Beijing, China). AFF3ir-ORF2-null (AFF3ir-ORF2^-/-) mice were acquired from Dr. Lingfang Zeng’s Laboratory at King’s College London (Zhao Y et al., 2024). To generate ApoE and AFF3ir-ORF2 double knockout mice (ApoE^-/-AFF3ir-ORF2^-/-), ApoE^-/- mice were crossed with AFF3ir-ORF2^-/- mice. The animals were maintained at 21 ± 1°C under a 12-hour light/dark cycle (lights on at 07:00, lights off at 19:00) with ad libitum access to water and standard chow unless specified otherwise. This study adhered to the Guide for the Care and Use of Laboratory Animals of the US National Institutes of Health (NIH Publication No. 85-23, revised 2011). All study protocols were approved by the Institutional Animal Care and Use Committee of Tianjin Medical University.

Carotid artery partial ligation surgery

The surgery was performed as we previously described (Yang et al., 2021). Briefly, mice were anesthetized with isoflurane (2-3%). A ventral midline incision (4-5 mm) was made in the neck and the left carotid artery was exposed through blunt dissection of subcutaneous fat and muscle tissue. The left external carotid, internal carotid, and occipital arteries were ligated with a 6-0 silk suture, leaving the superior thyroid artery intact. For adenovirus and lentivirus infection studies, adenovirus (Ad-ORF2 or Ad-Scramble) or lentivirus (lenti-shRNA-IRF5 or lenti-shRNA-Scramble) was introduced into the lumen of the left carotid artery and kept inside for 40 min. After infection, the adenovirus or lentivirus was released, and blood flow to the common carotid artery was restored. Mice were fed with a high-fat diet (TD88137, ENVIGO, USA) immediately after surgery and continued for 4 weeks.

Endothelial AFF3ir-ORF2 overexpression in mice

Endothelial-specific adeno-associated virus (AAV)-mediated CRISPR/Cas9 shuttle plasmid was constructed by Cell & Gene Therapy (Shanghai, China) as previously reported (Wang et al., 2016). ApoE^-/- mice received a single tail vein injection of recombinant AAV containing an endothelial-specific human ICAM-2 promoter driving AFF3ir-ORF2 overexpression (AAV-AFF3ir-ORF2) or a control empty vector (AAV-Scramble), with a dose of 1×10¹¹ viral genomes in a 200 μL volume of sterile PBS. Subsequently, the mice were fed with a high-fat diet (TD88137, ENVIGO, USA) for 3 months.

Oil-Red O staining for atherosclerotic plaques in mouse aorta

The ApoE^-/-, ApoE^-/-AFF3ir-ORF2^-/-, and EC-specific AFF3ir-ORF2 overexpression mice were anaesthetized by inhalation of 2% isoflurane and euthanized by cervical dislocation. The aortas were dissected in 1×PBS and opened to expose the atherosclerotic plaques. After fixation in 4% formaldehyde for 1 hat 4 °C, the tissues were rinsed in water for 10 min, followed by 60% isopropanol. The aortas were then stained with Oil-Red O for 30 min with gentle shaking, rinsed again in 60% isopropanol, and subsequently rinsed in water three times. The samples were mounted on wax with the endothelial surface facing upwards. Images were captured using an HP Scanjet G4050. Plaque areas were quantified using NIH ImageJ software by calculating the plaque area relative to the total vascular area.

Immunofluorescence staining

MEFs slides or frozen sections were fixed in 4% paraformaldehyde for 30 min, then permeabilized in 0.1% Triton X-100 (in PBS) and blocked with 1% bovine serum albumin for 30 min at room temperature. Sections were incubated overnight at 4°C with primary antibodies (1:100). The vWF (Cat. No. ab11713) and VE-Cadherin (Cat. No. ab33168) antibodies were obtained from Abcam (Cambridge, UK). VCAM-1 (Cat. No. sc-13160) antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Following primary antibody incubation, sections were treated with Alexa Fluor 488- or Alexa Fluor 594- conjugated secondary antibodies (1:200, Thermo Fisher Scientific, Grand Island, NY, USA) at room temperature for 1 hour. Slides were then mounted with DAPI-containing mounting medium. Antibody specificity and target staining authenticity were verified using negative controls. Immunofluorescence micrographs were acquired using a Leica confocal laser scanning microscope. Representative images were randomly selected from each group.

Histological analysis of atherosclerotic lesions

Harvested carotid arteries and cross-sections of aortic roots were fixed in 4% paraformaldehyde and embedded in optimal cutting temperature compound (OCT). OCT- embedded tissues were sectioned at a thickness of 7 μm. Slides were immersed in 1×PBS for 5 min to remove OCT, and subsequently stained with Oil-Red O, haematoxylin and eosin (HE), and Masson’s trichrome stain to assess lipid accumulation, lesion area, and collagen deposition, respectively (B. Li et al., 2019). Images were acquired using microscopy.

Quantification of plasma lipid levels

Blood samples were obtained via cardiac puncture, rinsed with heparin, and collected in 1.5 15 mL Eppendorf tubes. Total plasma cholesterol, triglycerides, LDL cholesterol, and HDL cholesterol levels were measured enzymatically using an automated clinical chemistry analyser kit (Biosino Biotech, Beijing, China).

Cell culture, transfection, and shear stress experiments

Mouse Embryonic Fibroblasts (MEFs) were obtained and cultured as previously described (Ferreira & Hein, 2023). Cell passages 4 to 7 were used in all experiments. MEFs and HEK293 cells were cultured in the Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL). Cells were incubated at 37°C in a humidified environment containing 5% CO₂ and grown to 70- 80% confluence before treatment.

Small interfering RNA against IRF5 or IRF8 were synthesized from General Biosystems (Hefei, China). The sequences of siRNAs are shown in the Table S1. The MEFs were passaged to 6-well plated and transfected with 20 nmol/L siRNA per well using the Lipofectamine RNA iMAX Reagent (Invitrogen, Carlsbad, CA, USA).

For flow experiments, confluent monolayers of MEFs were seeded onto glass slides, and a parallel plate flow system was used to launch oscillatory flow (0.5 ± 4 dyn/cm²). The flow system was enclosed in a chamber (Frangos, Eskin, McIntire, & Ives, 1985; Fu et al., 2011).

Adenovirus and lentivirus production and infection

AFF3ir-ORF2 sequences were inserted into the GV138 vector (CMV-MCS-3FLAG) to generate recombinant adenovirus (Ad-AFF3ir-ORF2). The short hairpin RNA (shRNA) sequences targeting mouse IRF5 were 5’-GGGACAACACCATCTTCAAGG-3’, 5’GGTTGCTGCTGGAGATGTTCT-3’, and 5’-GCCTAGAGCAGTTTCTCAATG-3’. The control shRNA was 5’-GCGTGATCTTCACCGACAAGA-3’. These shRNAs were constructed and cloned into pLV-U6-shRNA-CMV-EGFP to generate recombinant lentivirus (lenti-shRNA-IRF5 or lenti-shCtrl). MEFs were infected with adenovirus or lentivirus at a multiplicity of infection (MOI) of 10, with no detectable cellular toxicity observed.

Western blot analysis

Whole-cell lysates were prepared in a lysis buffer containing a complete protease inhibitor cocktail, PhosSTOP, and PMSF (Roche, Mannheim, Germany). Cytoplasmic and nuclear proteins were extracted from wild-type and AFF3ir-ORF2^-/- MEFs using a protein extraction kits (Invent Biotechnologies, SC-003, Beijing, China). Protein were separated by SDS-PAGE and transferred to nitrocellulose membranes (Cat. No. 10600001; GE Healthcare; Chicago, IL, 16 USA). The membranes were incubated with primary antibodies. IRF5 (Cat. No. 96527), IRF8 (Cat. No. 98344), and Flag (Cat. No. 14793) antibodies were from Cell Signaling Technology (Danvers, MA, USA). ICAM-1 (Cat. No. ab222736) antibodies were from Abcam (Cambridge, UK). AFF3ir-ORF2 (Cat. No. C0302HL300-4) and AFF3ir-ORF1 (Cat. No. C0302HL300) antibodies were from GenScript (NJ, USA). GAPDH (Cat. No. 60004-1-Ig) antibody was from Proteintech (Wuhan, China). AFF3 (Cat. No. PA5-68961) antibody was from Thermo Fisher Scientific (Waltham, MA, USA).

After incubation with horseradish peroxidase-conjugated secondary antibodies, the proteins were visualized using enhanced chemiluminescence reagents in a ChemiScope3600 Mini chemiluminescence imaging system (Clinx Science Instruments; Shanghai, China). Protein levels were quantified by measuring integrated density with NIH Image J software (https://imagej.nih.gov/ij/), using GAPDH as a loading control for normalization.

Co-immunoprecipitation

Whole-cell lysates were prepared by lysing cells in a 1% NP-40 lysis buffer containing 50 mM Tris-HCl, 1% Nonidet-P40, 0.1% SDS, and 150 mM NaCl, supplemented with a complete protease inhibitor cocktail (Cat. No. 04693132001; Roche, Indianapolis, IN, USA), a phosphatase inhibitor (PhosSTOP; Cat. No. 04906845001; Roche), and PMSF (Cat. No. IP0280; Solarbio Life Sciences; Beijing, China). Samples were incubated on ice for 30 minutes, then centrifuged at 12,000 g for 10 minutes, and the supernatant was transferred to a new tube. Protein concentrations were determined using the BCA Protein Assay Kit (Thermo Fisher Scientific, Grand Island, NY, USA).

For immunoprecipitation, 1000 μg of protein was incubated with specific antibodies at 4 °C for 12 hour with constant rotation. Subsequently, 50 μL of 50% Protein A/G PLUS-Agarose beads was added, and the incubation continued for an additional 2 hr. Beads were washed five times with the lysis buffer and collected by centrifugation at 12,000 g for 2 min at 4°C. After the final wash, the supernatant was removed and discarded. Precipitated proteins were eluted by resuspending the beads in 2×SDS-PAGE loading buffer and boiling for 5 min. The eluates from immunoprecipitation were subjected to Western blot analysis.

Total RNA extraction and real-time quantitative PCR analysis

Total RNA was extracted from cells using an RNA extraction kits (Transgen Biotech, ER501- 01, Beijing, China). Reverse transcription was performed with a reverse transcription kit (Thermo Fisher Scientific, Grand Island, NY, USA). Quantitative PCR was conducted using SYBR Select (Thermo Fisher Scientific) according to the manufacturer’s protocol, with GAPDH serving as the internal control. The primers for quantitative real-time PCR are listed in Supplementary Table 2.

Luciferase reporter assay

The IRF5-binding motif and the full-length ZNF217 promoter were ligated into pGl3-based plasmids (Genechem, Shanghai, China), as previously described (Qiao et al., 2022). HEK293T cells were seeded into 24-well plates and grown to 70-80% confluency. Cells were transfected with the firefly luciferase reporter plasmid containing the IRF5-responsive ZNF217 promoter along with a β-galactosidase reporter plasmid (Promega, Madison, WI, USA) for 24 hour. Subsequently, cells were then infected with adenovirus (Ad-ORF2 or Ad- Scramble) for an additional 24 hour. Relative luciferase activity was measured using a luciferase assay and normalized to β-galactosidase activity as determined by the β- Galactosidase Enzyme Assay System (Promega, Madison, WI, USA).

RNA-sequencing (RNA-seq)

RNA-seq was performed as we previously described (Z. Li et al., 2024). Wild-type (WT) and AFF3ir-ORF2^-/- MEFs were harvested, and RNA was extracted using the MagicPure Total RNA Kit (TransGen, Beijing, China). Whole transcriptome RNA-seq analysis were conducted by the Beijing Genomics Institute (BGI). Paired-end sequencing in 150-bp length was performed using the DNBSEQ-G400 platform. Raw data was filtrated using SOAPnuke (v1.5.6). Differential gene expression analysis, with thresholds set at P < 0.05 and fold change ≥1.5, was performed via the BGI website (http://omiscribe.bgi.com). Pathway enrichment analysis was carried out using DAVID tools.

Statistical analysis

Statistics analyses were performed using GraphPad Prism 8.0. No sample outliers were excluded. At least six independent experiments were performed for all biochemical experiments and the representative images were shown. Unpaired Student’s t test (2-tailed), 1- way ANOVA or 2-way ANOVA with Bonferroni multiple comparison post hoc test were used for analyses, as appropriate. Sample size, statistical method, and statistical significance are specified in Figures and Figure Legends. Levels of probabilities less than 0.05 were regarded as significant.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Acknowledgements

This work was supported by National Natural Science Foundation of China Grants (82330012, 82127808, 82270516, and 82070451), British Heart Foundation (FS-15/74/31669), Tianjin Science and Technology Program of China [21JCYBJC01590], and Research Project of Tianjin Municipal Health Commission [2023013].

Disclosures

None.

References

1. Almuttaqi H.
2. Udalova I. A
2019Advances and challenges in targeting IRF5, a key regulator of inflammationFebs J 286:1624–1637https://doi.org/10.1111/febs.14654
1. Alzaid F.
2. Lagadec F.
3. Albuquerque M.
4. Ballaire R.
5. Orliaguet L.
6. Hainault I.
7. …
8. Venteclef N.
2016IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humansJCI Insight 1https://doi.org/10.1172/jci.insight.88689
1. Bennett M. R.
2. Sinha S.
3. Owens G. K
2016Vascular Smooth Muscle Cells in AtherosclerosisCirc Res 118:692–702https://doi.org/10.1161/CIRCRESAHA.115.306361
1. Cai H.
2. Yao Z.
3. Li W
2017IRF-5 accelerates leukocyte adhesion to endothelial cells in ischemia-reperfusion injury through regulating the transcription of VCAM-1Biochem Biophys Res Commun 492:192–198https://doi.org/10.1016/j.bbrc.2017.08.044
1. Chen Z.
2. Peng I. C.
3. Cui X.
4. Li Y. S.
5. Chien S.
6. Shyy J. Y
2010Shear stress, SIRT1, and vascular homeostasisProc Natl Acad Sci U S A 107:10268–10273https://doi.org/10.1073/pnas.1003833107
1. Courties G.
2. Heidt T.
3. Sebas M.
4. Iwamoto Y.
5. Jeon D.
6. Truelove J.
7. …
8. Nahrendorf M.
2014In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healingJ Am Coll Cardiol 63:1556–1566https://doi.org/10.1016/j.jacc.2013.11.023
1. Dalmas E.
2. Toubal A.
3. Alzaid F.
4. Blazek K.
5. Eames H. L.
6. Lebozec K.
7. …
8. Venteclef N.
2015Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesityNat Med 21:610–618https://doi.org/10.1038/nm.3829
1. Davignon J.
2. Ganz P
2004Role of endothelial dysfunction in atherosclerosisCirculation 109:III27–32https://doi.org/10.1161/01.CIR.0000131515.03336.f8
1. Davis M. J.
2. Earley S.
3. Li Y. S.
4. Chien S
2023Vascular mechanotransductionPhysiological Reviews 103:1247–1421https://doi.org/10.1152/physrev.00053.2021
1. Ferreira R.
2. Hein N
2023Purification of Mouse Embryonic Fibroblasts (MEFs)Curr Protoc 3https://doi.org/10.1002/cpz1.921
1. Frangos J. A.
2. Eskin S. G.
3. McIntire L. V.
4. Ives C. L
1985Flow effects on prostacyclin production by cultured human endothelial cellsScience 227:1477–1479https://doi.org/10.1126/science.3883488
1. Fu Y.
2. Hou Y.
3. Fu C.
4. Gu M.
5. Li C.
6. Kong W.
7. …
8. Zhu Y.
2011A novel mechanism of gamma/delta T-lymphocyte and endothelial activation by shear stress: the role of ecto-ATP synthase beta chainCirc Res 108:410–417https://doi.org/10.1161/CIRCRESAHA.110.230151
1. Graham R. R.
2. Kozyrev S. V.
3. Baechler E. C.
4. Reddy M. V.
5. Plenge R. M.
6. Bauer J. W.
7. …
8. Alarcon-Riquelme M. E.
2006A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosusNat Genet 38:550–555https://doi.org/10.1038/ng1782
1. Herrington W.
2. Lacey B.
3. Sherliker P.
4. Armitage J.
5. Lewington S
2016Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic DiseaseCirc Res 118:535–546https://doi.org/10.1161/CIRCRESAHA.115.307611
1. Hwang J.
2. Saha A.
3. Boo Y. C.
4. Sorescu G. P.
5. McNally J. S.
6. Holland S. M.
7. …
8. Jo H.
2003Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesionJournal of Biological Chemistry 278:47291–47298https://doi.org/10.1074/jbc.M305150200
1. Jo H.
2. Song H.
3. Mowbray A
2006Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosisAntioxid Redox Signal 8:1609–1619https://doi.org/10.1089/ars.2006.8.1609
1. Keenan A. B.
2. Torre D.
3. Lachmann A.
4. Leong A. K.
5. Wojciechowicz M. L.
6. Utti V.
7. …
8. Ma’ayan A.
2019ChEA3: transcription factor enrichment analysis by orthogonal omics integrationNucleic Acids Res 47:W212–W224https://doi.org/10.1093/nar/gkz446
1. Kobiyama K.
2. Ley K
2018AtherosclerosisCirc Res 123:1118–1120https://doi.org/10.1161/circresaha.118.313816
1. Krausgruber T.
2. Blazek K.
3. Smallie T.
4. Alzabin S.
5. Lockstone H.
6. Sahgal N.
7. …
8. Udalova I. A.
2011IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responsesNat Immunol 12:231–238https://doi.org/10.1038/ni.1990
1. Lazzari E.
2. Korczeniewska J.
3. Ni Gabhann J.
4. Smith S.
5. Barnes B. J.
6. Jefferies C. A
2014TRIpartite motif 21 (TRIM21) differentially regulates the stability of interferon regulatory factor 5 (IRF5) isoformsPLoS One 9https://doi.org/10.1371/journal.pone.0103609
1. Leipner J.
2. Dederichs T. S.
3. von Ehr A.
4. Rauterberg S.
5. Ehlert C.
6. Merz J.
7. …
8. Hardtner C.
2021Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(-/-) miceMol Metab 53https://doi.org/10.1016/j.molmet.2021.101250
1. Li B.
2. He J.
3. Lv H.
4. Liu Y.
5. Lv X.
6. Zhang C.
7. …
8. Ai D.
2019c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flowJ Clin Invest 129:1167–1179https://doi.org/10.1172/JCI122440
1. Li Z.
2. Zhang J.
3. Ma Z.
4. Zhao G.
5. He X.
6. Yu X.
7. …
8. He J.
2024Endothelial YAP Mediates Hyperglycemia-Induced Platelet Hyperactivity and Arterial ThrombosisArterioscler Thromb Vasc Biol 44:254–270https://doi.org/10.1161/ATVBAHA.123.319835
1. Libby P.
2. Buring J. E.
3. Badimon L.
4. Hansson G. K.
5. Deanfield J.
6. Bittencourt M. S.
7. …
8. Lewis E. F.
2019AtherosclerosisNat Rev Dis Primers 5https://doi.org/10.1038/s41572-019-0106-z
1. Lv J. J.
2. Wang H.
3. Zhang C.
4. Zhang T. J.
5. Wei H. L.
6. Liu Z. K.
7. …
8. Bian H.
2024CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing EfferocytosisCirc Res 134:165–185https://doi.org/10.1161/circresaha.123.323223
1. Masuda T.
2. Iwamoto S.
3. Yoshinaga R.
4. Tozaki-Saitoh H.
5. Nishiyama A.
6. Mak T. W.
7. …
8. Inoue K.
2014Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic painNat Commun 5https://doi.org/10.1038/ncomms4771
1. Nakashima Y.
2. Raines E. W.
3. Plump A. S.
4. Breslow J. L.
5. Ross R
1998Upregulation of VCAM- 1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouseArterioscler Thromb Vasc Biol 18:842–851https://doi.org/10.1161/01.atv.18.5.842
1. Nam D.
2. Ni C. W.
3. Rezvan A.
4. Suo J.
5. Budzyn K.
6. Llanos A.
7. …
8. Jo H.
2009Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosisAm J Physiol Heart Circ Physiol 297:H1535–1543https://doi.org/10.1152/ajpheart.00510.2009
1. Pinero J.
2. Bravo A.
3. Queralt-Rosinach N.
4. Gutierrez-Sacristan A.
5. Deu-Pons J.
6. Centeno E.
7. …
8. Furlong L. I.
2017DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variantsNucleic Acids Res 45:D833–D839https://doi.org/10.1093/nar/gkw943
1. Qiao X.
2. Lv S.
3. Qiao Y.
4. Wang F.
5. Miao L
2022Interferon regulatory factor 5-induced upregulation of zinc-finger protein 217 promotes pancreatic carcinoma progressionMol Med Rep 25https://doi.org/10.3892/mmr.2022.12705
1. Roberts B. K.
2. Collado G.
3. Barnes B. J
2024Role of interferon regulatory factor 5 (IRF5) in tumor progression: Prognostic and therapeutic potentialBiochim Biophys Acta Rev Cancer 1879https://doi.org/10.1016/j.bbcan.2023.189061
1. Salem S.
2. Salem D.
3. Gros P
2020Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseasesHum Genet 139:707–721https://doi.org/10.1007/s00439-020-02154-2
1. Saliba D. G.
2. Heger A.
3. Eames H. L.
4. Oikonomopoulos S.
5. Teixeira A.
6. Blazek K.
7. …
8. Udalova I. A.
2014IRF5:RelA interaction targets inflammatory genes in macrophagesCell Rep 8:1308–1317https://doi.org/10.1016/j.celrep.2014.07.034
1. Sato M.
2. Taniguchi T.
3. Tanaka N
2001The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout miceCytokine Growth Factor Rev 12:133–142https://doi.org/10.1016/s1359-6101(00)00032-0
1. Savitsky D. A.
2. Yanai H.
3. Tamura T.
4. Taniguchi T.
5. Honda K
2010Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locusProc Natl Acad Sci U S A 107:10154–10159https://doi.org/10.1073/pnas.1005599107
1. Seneviratne A. N.
2. Edsfeldt A.
3. Cole J. E.
4. Kassiteridi C.
5. Swart M.
6. Park I.
7. …
8. Monaco C.
2017Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing EfferocytosisCirculation 136:1140–1154https://doi.org/10.1161/CIRCULATIONAHA.117.027844
1. Sorescu G. P.
2. Song H.
3. Tressel S. L.
4. Hwang J.
5. Dikalov S.
6. Smith D. A.
7. …
8. Jo H.
2004Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidaseCirc Res 95:773–779https://doi.org/10.1161/01.RES.0000145728.22878.45
1. Swiech L.
2. Heidenreich M.
3. Banerjee A.
4. Habib N.
5. Li Y.
6. Trombetta J.
7. …
8. Zhang F.
2015In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9Nat Biotechnol 33:102–106https://doi.org/10.1038/nbt.3055
1. Takaoka A.
2. Yanai H.
3. Kondo S.
4. Duncan G.
5. Negishi H.
6. Mizutani T.
7. …
8. Taniguchi T.
2005Integral role of IRF-5 in the gene induction programme activated by Toll-like receptorsNature 434:243–249https://doi.org/10.1038/nature03308
1. Wang L.
2. Luo J. Y.
3. Li B.
4. Tian X. Y.
5. Chen L. J.
6. Huang Y.
7. …
8. Huang Y.
2016Integrin- YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flowNature 540:579–582https://doi.org/10.1038/nature20602
1. Weiss M.
2. Blazek K.
3. Byrne A. J.
4. Perocheau D. P.
5. Udalova I. A
2013IRF5 is a specific marker of inflammatory macrophages in vivoMediators Inflamm 2013https://doi.org/10.1155/2013/245804
1. Weiss M.
2. Byrne A. J.
3. Blazek K.
4. Saliba D. G.
5. Pease J. E.
6. Perocheau D.
7. …
8. Udalova I. A.
2015IRF5 controls both acute and chronic inflammationProc Natl Acad Sci U S A 112:11001–11006https://doi.org/10.1073/pnas.1506254112
1. Wen L.
2. Chen Z.
3. Zhang F.
4. Cui X.
5. Sun W.
6. Geary G. G.
7. …
8. Shyy J. Y.
2013Ca2+/calmodulin- dependent protein kinase kinase beta phosphorylation of Sirtuin 1 in endothelium is atheroprotectiveProc Natl Acad Sci U S A 110:E2420–2427https://doi.org/10.1073/pnas.1309354110
1. Wolf D.
2. Ley K
2019Immunity and Inflammation in AtherosclerosisCirc Res 124:315–327https://doi.org/10.1161/CIRCRESAHA.118.313591
1. Yang Y.
2. Ma Q.
3. Li Z.
4. Wang H.
5. Zhang C.
6. Liu Y.
7. …
8. He J.
2021Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAPBr J Pharmacol 178:1524–1540https://doi.org/10.1111/bph.15378
1. Zhang C.
2. Zhou T.
3. Chen Z.
4. Yan M.
5. Li B.
6. Lv H.
7. …
8. Ai D.
2020Coupling of Integrin alpha5 to Annexin A2 by Flow Drives Endothelial ActivationCirc Res 127:1074–1090https://doi.org/10.1161/CIRCRESAHA.120.316857
1. Zhao Y
2. Ehteramyan M
3. Li Y
4. Bai X
5. Huang L
6. Gao Y
7. …
8. Zeng L.
2024A novel nested gene Aff3ir participates in vascular remodeling by enhancing endothelial cell differentiation in miceGenes & Diseases https://doi.org/10.1016/j.gendis.2024.101339

Article and author information

Author information

Shuo He
Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China;
- These authors contributed equally to this study.
Lei Huang
Department of Heart Center, The Third Central Hospital of Tianjin, Tianjin, China;, Nankai University Affiliated Third Center Hospital, Tianjin, China;
- These authors contributed equally to this study.
Zhuozheng Chen
Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China;
Ze Yuan
Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China;
Yue Zhao
Department of Heart Center, The Third Central Hospital of Tianjin, Tianjin, China;, School of Cardiovascular and Metabolic Medicine and Sciences, King’s College London British Heart Foundation Centre of Excellence, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom
ORCID iD: 0000-0002-6818-2352
Lingfang Zeng
School of Cardiovascular and Metabolic Medicine and Sciences, King’s College London British Heart Foundation Centre of Excellence, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom
ORCID iD: 0000-0002-0390-4561
- For correspondence: lingfang.zeng@kcl.ac.uk
Yi Zhu
Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China;
- For correspondence: zhuyi@tmu.edu.cn
Jinlong He
Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China;
ORCID iD: 0000-0001-7349-8135
- For correspondence: hejinlong@tmu.edu.cn

Version history

Sent for peer review: October 3, 2024
Preprint posted: October 4, 2024
Reviewed Preprint version 1: December 13, 2024

Copyright

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

views: 32
downloads: 0
citations: 0

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Significance of findings

Strength of evidence

Abstract

Introduction

Results

Disturbed shear stress reduces the expression of AFF3ir-ORF2

Disturbed shear stress reduces the expression of AFF3ir-ORF2 in vivo and in vitro.

AFF3ir-ORF2 ameliorates disturbed shear stress-induced inflammation and atherosclerosis

AFF3ir-ORF2 overexpression alleviates disturbed flow-induced inflammation and atherosclerosis.

AFF3ir-ORF2 deficiency aggravates inflammation and atherosclerotic lesions in ApoE-/- mice

AFF3ir-ORF2 deletion aggravates inflammation and atherosclerotic lesions in ApoE-/- mice.

AFF3ir-ORF2 mitigates disturbed shear stress-induced inflammation by interacting with IRF5 and retaining it within the cytosol

AFF3ir-ORF2 mitigates disturbed shear stress-induced inflammation by interacting with IRF5 and retaining it within the cytosol.

IRF5 knockdown prevents the aggravation of atherosclerosis induced by ORF2 deficiency

IRF5 knockdown prevents the aggravation of atherosclerosis in AFF3ir-ORF2 deficienct mice.

Endothelial-specific AFF3ir-ORF2 supplementation ameliorates EC activation and atherosclerosis in mice

Endothelial-specific AFF3ir-ORF2 supplementation alleviates EC activation and atherosclerosis in ApoE-/- mice.

Discussion

Schematic illustration of the AFF3ir-ORF2/IRF5 cascade in disturbed flow-induced endothelial activation and atherosclerosis.

Conclusion

Materials and methods

Animals

Carotid artery partial ligation surgery

Endothelial AFF3ir-ORF2 overexpression in mice

Oil-Red O staining for atherosclerotic plaques in mouse aorta

Immunofluorescence staining

Histological analysis of atherosclerotic lesions

Quantification of plasma lipid levels

Cell culture, transfection, and shear stress experiments

Adenovirus and lentivirus production and infection

Western blot analysis

Co-immunoprecipitation

Total RNA extraction and real-time quantitative PCR analysis

Luciferase reporter assay

RNA-sequencing (RNA-seq)

Statistical analysis

Data availability statement

Acknowledgements

Disclosures

References

Article and author information

Author information

Shuo He#

Lei Huang#

Zhuozheng Chen

Ze Yuan

Yue Zhao

Lingfang Zeng

Yi Zhu

Jinlong He

Version history

Copyright

Metrics

AFF3ir-ORF2 deficiency aggravates inflammation and atherosclerotic lesions in ApoE^-/- mice

AFF3ir-ORF2 deletion aggravates inflammation and atherosclerotic lesions in ApoE^-/- mice.

Endothelial-specific AFF3ir-ORF2 supplementation alleviates EC activation and atherosclerosis in ApoE^-/- mice.

Shuo He

Lei Huang